Literature DB >> 21390379

Inhibition of 2-oxoglutarate dependent oxygenases.

Nathan R Rose1, Michael A McDonough, Oliver N F King, Akane Kawamura, Christopher J Schofield.   

Abstract

2-Oxoglutarate (2OG) dependent oxygenases are ubiquitous iron enzymes that couple substrate oxidation to the conversion of 2OG to succinate and carbon dioxide. In humans their roles include collagen biosynthesis, fatty acid metabolism, DNA repair, RNA and chromatin modifications, and hypoxic sensing. Commercial applications of 2OG oxygenase inhibitors began with plant growth retardants, and now extend to a clinically used pharmaceutical compound for cardioprotection. Several 2OG oxygenases are now being targeted for therapeutic intervention for diseases including anaemia, inflammation and cancer. In this critical review, we describe studies on the inhibition of 2OG oxygenases, focusing on small molecules, and discuss the potential of 2OG oxygenases as therapeutic targets (295 references). This journal is © The Royal Society of Chemistry 2011

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21390379     DOI: 10.1039/c0cs00203h

Source DB:  PubMed          Journal:  Chem Soc Rev        ISSN: 0306-0012            Impact factor:   54.564


  167 in total

Review 1.  Epigenetics in myelodysplastic syndromes.

Authors:  Michael Heuser; Haiyang Yun; Felicitas Thol
Journal:  Semin Cancer Biol       Date:  2017-08-02       Impact factor: 15.707

2.  CYSL-1 interacts with the O2-sensing hydroxylase EGL-9 to promote H2S-modulated hypoxia-induced behavioral plasticity in C. elegans.

Authors:  Dengke K Ma; Roman Vozdek; Nikhil Bhatla; H Robert Horvitz
Journal:  Neuron       Date:  2012-03-08       Impact factor: 17.173

3.  Plant growth regulator daminozide is a selective inhibitor of human KDM2/7 histone demethylases.

Authors:  Nathan R Rose; Esther C Y Woon; Anthony Tumber; Louise J Walport; Rasheduzzaman Chowdhury; Xuan Shirley Li; Oliver N F King; Clarisse Lejeune; Stanley S Ng; Tobias Krojer; Mun Chiang Chan; Anna M Rydzik; Richard J Hopkinson; Ka Hing Che; Michelle Daniel; Claire Strain-Damerell; Carina Gileadi; Grazyna Kochan; Ivanhoe K H Leung; James Dunford; Kar Kheng Yeoh; Peter J Ratcliffe; Nicola Burgess-Brown; Frank von Delft; Susanne Muller; Brian Marsden; Paul E Brennan; Michael A McDonough; Udo Oppermann; Robert J Klose; Christopher J Schofield; Akane Kawamura
Journal:  J Med Chem       Date:  2012-07-11       Impact factor: 7.446

Review 4.  Alterations of metabolic genes and metabolites in cancer.

Authors:  Eric K Oermann; Jing Wu; Kun-Liang Guan; Yue Xiong
Journal:  Semin Cell Dev Biol       Date:  2012-01-28       Impact factor: 7.727

5.  Combination Targeted Therapy to Disrupt Aberrant Oncogenic Signaling and Reverse Epigenetic Dysfunction in IDH2- and TET2-Mutant Acute Myeloid Leukemia.

Authors:  Alan H Shih; Cem Meydan; Kaitlyn Shank; Francine E Garrett-Bakelman; Patrick S Ward; Andrew M Intlekofer; Abbas Nazir; Eytan M Stein; Kristina Knapp; Jacob Glass; Jeremy Travins; Kim Straley; Camelia Gliser; Christopher E Mason; Katharine Yen; Craig B Thompson; Ari Melnick; Ross L Levine
Journal:  Cancer Discov       Date:  2017-02-13       Impact factor: 39.397

Review 6.  Catalytic Mechanisms of Fe(II)- and 2-Oxoglutarate-dependent Oxygenases.

Authors:  Salette Martinez; Robert P Hausinger
Journal:  J Biol Chem       Date:  2015-07-07       Impact factor: 5.157

Review 7.  Introduction: Metals in Biology: α-Ketoglutarate/Iron-Dependent Dioxygenases.

Authors:  F Peter Guengerich
Journal:  J Biol Chem       Date:  2015-07-07       Impact factor: 5.157

Review 8.  The TET enzymes.

Authors:  Peppi Koivunen; Tuomas Laukka
Journal:  Cell Mol Life Sci       Date:  2017-11-28       Impact factor: 9.261

Review 9.  Oxygen sensing strategies in mammals and bacteria.

Authors:  Cornelius Y Taabazuing; John A Hangasky; Michael J Knapp
Journal:  J Inorg Biochem       Date:  2014-01-03       Impact factor: 4.155

Review 10.  HIF prolyl hydroxylase inhibitors for the treatment of renal anaemia and beyond.

Authors:  Patrick H Maxwell; Kai-Uwe Eckardt
Journal:  Nat Rev Nephrol       Date:  2015-12-14       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.